Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: Real-world Evidence Study on Cystistat

View source ↗

Summary

Real-world evidence study of Cystistat (sodium hyaluronate) in interstitial cystitis and bladder pain syndrome has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cystistat (Sodium hyaluronate)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Interstitial Cystitis and Bladder Pain Syndrome | Status: COMPLETED | Results posted: 2026-01-09